الولايات المتحدة · منصات وبيانات · TipRanks

PegBio’s Paidakang Included in China’s 2026 NRDL

نشره TipRanks · الولايات المتحدة منذ 10 س

ملخص مفصل

PegBio Co., Ltd. Class H ( ($HK:2565) ) has issued an announcement. PegBio is an innovative-drug developer focused on metabolic diseases; its first marketed ...

اقرأ المقال كاملًا على TipRanks سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.tipranks.com)

يستحق القراءة أيضًا

The Motley Fool

What To Expect In Markets This Week: NVDA, PANW, DIS, HD, TGT, WMT, GRRR Earnings, Kevin Warsh Speech And More

Seeking Alpha

PegBio’s Paidakang Included in China’s 2026 NRDL

ملخص مفصل

مشاركة

يستحق القراءة أيضًا

Prediction: Rigetti Computing Stock Will Be Worth This Much in 1 Year

German American Bancorp director Bawel buys $19,999 in shares

Bitcoin Faces Final Capitulation Risk: Could $40,000 Be Next?

Nvidia earnings collide with Fed’s biggest AI challenge under Warsh

What To Expect In Markets This Week: NVDA, PANW, DIS, HD, TGT, WMT, GRRR Earnings, Kevin Warsh Speech And More

Global oil market moves to surplus as Persian Gulf shipments rebound, IEA says